Certain HLA alleles (HLA-B*15:02 and HLA-A*31:01) are associated with elevated risk of developing Cutaneous Adverse Drug Reactions (cARDs), with SJS and TEN being notable examples [113,114]. This evidence concerns the gene HLA-A and toxic epidermal necrolysis.